Next Article in Journal
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)
Previous Article in Journal
Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
 
 
Article

Article Versions Notes

Cancers 2023, 15(20), 4998; https://doi.org/10.3390/cancers15204998
Action Date Notes Link
article xml file uploaded 16 October 2023 03:10 CEST Original file -
article xml uploaded. 16 October 2023 03:10 CEST Update https://www.mdpi.com/2072-6694/15/20/4998/xml
article pdf uploaded. 16 October 2023 03:10 CEST Version of Record https://www.mdpi.com/2072-6694/15/20/4998/pdf
article supplementary file uploaded. 16 October 2023 03:10 CEST - https://www.mdpi.com/2072-6694/15/20/4998#supplementary
article html file updated 16 October 2023 03:12 CEST Original file https://www.mdpi.com/2072-6694/15/20/4998/html
Back to TopTop